Precipio inc.

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScree...NEW HAVEN, Conn., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces the launch of …Precipio, Inc. NEW HAVEN, Conn., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO) today announced that it has implemented a 1-for-20 reverse ...NEW HAVEN, CT, (October 23rd, 2018) – Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched two new ICEme™ assays using its proprietary ICE-COLD PCR technology. The new ICEme assays cover PIK3CA exons 9 & 20, and achieve a level of sensitivity of 0.1%, enabling their use with liquid biopsies. They enhance Precipio’s breast ...Jul 30, 2020 · NEW HAVEN, Conn., July 30, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), is announcing its COVID-19 strategy, and its intent to contribute to the battle ...

Appointment of New Directors . On September 26, 2017, Precipio, Inc. (the “Company”) elected each of Douglas Fisher, M.D. and Jeffrey Cossman, M.D. to the Board of Directors of the Company (the “Board”) to fill existing vacancies on the Board, each to serve until the Company’s 2018 annual meeting of stockholders or his earlier resignation, retirement or …Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and ... On November 11, 2020, Precipio, Inc (the "Company") announced that management will host a Q3-2020 Corporate Update Call for Shareholders on Thursday, November 19th, 2020 at 5:00 PM EST. A copy of the letter is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Precipio, Inc. announced that Keith Meadors has joined Precipio as its Senior Vice President of its Products Division, to manage and drive company growth and market share. Keith brings over 30 years of executive experience in various healthcare organizations, including his recent position as Vice President of Marketing at Fresenius Kabi.Precipio, Inc. May 4, 2023 at 10:00 AM · 3 min read. Precipio, Inc. Customer’s revenues expected at $750K at full capacity. NEW HAVEN, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- Specialty cancer ...

Get the latest Precipio, Inc. (PRPO) stock news and headlines to help you in your trading and investing decisions.Precipio Corporate Deck. Who is Precipio? We are creating clinically impactful, cost-effective cancer diagnostic technologies to eliminate laboratory diagnostic errors. Discover how we excel as a blood cancer laboratory, dedicated to specialized diagnostic services for physicians and patients. Learn more at Precipio.(Bloomberg) -- Chinese stocks slid following a much-anticipated meeting between Presidents Joe Biden and Xi Jinping, as traders saw only modest progress in …Nov 29, 2023 · Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript. Seeking Alpha - Aug 17, 2023, 6:32PM. Precipio launches quantitative BCR-ABL 2.0 panel for patients with chronic myeloid leukemia.

Precipio, Inc Mar 2019 - Apr 2021 2 years 2 months. New Haven, Connecticut, USA Global business strategies and AI in Pathology initiative. Non Executive Chairman ...

Exhibit 99.1 . Precipio Takes Final Step towards Regaining Nasdaq Compliance. Company announces 1-for-15 reverse stock split . NEW HAVEN, CT - (April 26, 2019) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) today announced that it has implemented a 1-for-15 reverse stock split of outstanding shares of the company's …

On September 4, 2020, Precipio, Inc (the "Company") announced that management will host shareholder call to discuss the company's COVID-19 progress and future plans. The call will take place on Wednesday, September 9th at 5:00PM EST. Shareholders may submit their questions up until 5PM on September 7, 2020 by email to …Flow Cytometry Lead Technologist at Precipio, Inc West Haven, Connecticut, United States. 196 followers 195 connections See your mutual connections. View mutual connections with Kayley ...Registrant's telephone number, including area code (203) 787-7888. Not Applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and ...Nov 30, 2023 · A high-level overview of Precipio, Inc. (PRPO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Dec 6, 2022 · December 06, 2022 10:00 ET | Source: Precipio, Inc. NEW HAVEN, Conn., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced a 4-year ... Find the latest Precipio, Inc. (PRPO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Track Precipio Inc (PRPO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsPRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer Identification No.) 4 Science Park, New Haven, CT 06511 (Address of principal executive offices) (Zip Code)Flow Cytometry Lead Technologist at Precipio, Inc West Haven, Connecticut, United States. 196 followers 195 connections See your mutual connections. View mutual connections with Kayley ...Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and ...Precipio, Inc., and Subsidiary, (“we”, “us”, “our”, the “Company” or “Precipio”) is a cancer diagnostics company providing diagnostic products and services to the oncology market. We have built and continue to develop a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and ...Find the latest Precipio, Inc. (PRPO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Skillsoft’s online learning platform helps organizations to identify and measure skill proficiencies to ensure their workforce stays relevant. The platform makes skilling personalized and accessible, offering a blend of self-paced online courses, hands-on practice, virtual live online classes, and coaching to close skill gaps.Precipio’s platform delivers superior diagnostic accuracy through specialized expertise and cutting edge technology. We are a laboratory focused on delivering superior hematology …

Live Chat Inc. is a tool you can use to interact with customers or clients on the internet. More and more, consumers are demanding and expecting immediate help from the companies they approach. This application enables you to engage with cu...Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript. Seeking Alpha - Aug 17, 2023, 6:32PM. Precipio launches quantitative BCR-ABL 2.0 panel for patients with chronic myeloid leukemia.Precipio, Inc., and its subsidiaries, (collectively, “we”, “us”, “our”, the “Company” or “Precipio”) is a healthcare biotechnology company focused on cancer diagnostics. Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of ...On September 7, 2018, Precipio. Inc. (“we” or the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with Lincoln Park Capital Fund, LLC (“LPC”), pursuant to which we have the right to sell to LPC, and LPC has committed to purchase from us, from time to time, up to $10,000,000 of our common stock, subject to certain …Skillsoft’s online learning platform helps organizations to identify and measure skill proficiencies to ensure their workforce stays relevant. The platform makes skilling personalized and accessible, offering a blend of self-paced online courses, hands-on practice, virtual live online classes, and coaching to close skill gaps. Item 1.01. Entry into a Material Definitive Agreement. Merger Agreement . On October 12, 2016, Transgenomic, Inc. (“Transgenomic”), New Haven Labs Inc., a wholly owned subsidiary of Transgenomic (“Merger Sub” and, together with Transgenomic, the “Transgenomic Parties”), and Precipio Diagnostics, LLC (“Precipio”) entered into an …Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript August 17, 2023 Precipio, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1. Operator: Welcome to the ...We’re currently recruiting for the following positions: • Product Support Specialist, Products Division, (Hybrid/Remote) • Business Development Manager, Products Division, (Remote) • Cytogenetics FISH Technologist, Clinical Diagnostics Division (New Haven, CT) • Molecular Technologist I, Clinical Diagnostics Division (Omaha, NE)Invisible Fence Inc. is a leading provider of innovative pet containment and lifestyle solutions. With over 40 years of experience, Invisible Fence Inc. has developed products that are designed to keep pets safe and secure in their own yard...Dear Sirs: Reference is hereby made to (i) that certain Underwriting Agreement, dated as of August 22, 2017, by and between Precipio, Inc., a Delaware corporation (the “Company”), and Aegis Capital Corp. (“Aegis”), and (ii) that certain Placement Agency Agreement, dated November 2, 2017 and amended on November 9, 2017, by and between the Company …

NEW HAVEN, Conn., June 07, 2023 -- Specialty cancer diagnostics company Precipio, Inc. , announces that several operational improvement initiatives which commenced at the start of the year have...

NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched the HemeScreen ® Anemia Panel as part of its suite ...

Precipio Inc. PRPO (U.S.: Nasdaq) Overview News Precipio Inc. No significant news for in the past two years. Key Stock Data Shares Sold Short 295,864 Change from Last -9.22% Percent of Float...August 13, 2023 at 10:16 AM · 3 min read. It's not a stretch to say that Precipio, Inc.'s ( NASDAQ:PRPO) price-to-sales (or "P/S") ratio of 0.9x right now seems quite "middle-of-the-road" for ...Precipio, Inc., and Subsidiary, (“we”, “us”, “our”, the “Company” or “Precipio”) is a cancer diagnostics company providing diagnostic products and services to the oncology market. We have built and continue to develop a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and ...On May 14, 2021, Precipio, Inc (the "Company") announced that management will host a Q1-2021 and year-end Shareholder Update Call on Thursday, May 20th at 5:00 PM EST. A copy of the letter is attached hereto as Exhibit 99.1 and incorporated herein by reference.Clinical Services. 1 in 4 Hematopathology patients are misdiagnosed or misclassified. Our Omnia approach provides accuracy with our advanced cutting-edge technology. Learn more.Hina Naushad Qureishi, MD. Dr. Hina Qureishi joined Precipio Inc. as a hematopathologist with 18 years of experience in clinical practice and training residents and fellows at academic institutions. Dr. Qureishi was a faculty member at the University of Nebraska Medical Center in Omaha (2012-2022) and an Associate Professor of Pathology. On August 22, 2017, Precipio, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp. (“Aegis”), relating to the issuance and sale of 6,000 units consisting of one share of the Company’s Series B Preferred Stock, par value $0.01 per share (“Series B Preferred Stock”), which is convertible into 400 …Oct 23, 2018 · NEW HAVEN, CT, (October 23rd, 2018) – Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched two new ICEme™ assays using its proprietary ICE-COLD PCR technology. The new ICEme assays cover PIK3CA exons 9 & 20, and achieve a level of sensitivity of 0.1%, enabling their use with liquid biopsies. They enhance Precipio’s breast ... Precipio, Inc. 4 Science Park . New Haven, Connecticut 06511 (203) 787-7888 (Name, address, including zip code and telephone number, including area code, of agent for service) Copies to: Thomas A. Rose . Sichenzia Ross Ference LLP. 1185 Avenue of the Americas, 37th Floor. New York, NY 10036On November 11, 2020, Precipio, Inc (the "Company") announced that management will host a Q3-2020 Corporate Update Call for Shareholders on Thursday, November 19th, 2020 at 5:00 PM EST. A copy of the letter is attached hereto as Exhibit 99.1 and incorporated herein by reference.Precipio, Inc. Hospitals and Health Care New Haven, CT GeneDx ... Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and ...

Nov 29, 2023 · Precipio, Inc. (NASDAQ:PRPO) posted its earnings results on Thursday, August, 23rd. The biotechnology company reported ($3.00) earnings per share (EPS) for the quarter, missing the consensus estimate of $38.60 by $41.60. The biotechnology company had revenue of $0.82 million for the quarter. PRECIPIO, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 74019L107 (CUSIP Number) June 29, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ...Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScree...NEW HAVEN, Conn., June 08, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced it has entered into securities purchase agreements with ...Instagram:https://instagram. tennis guadalajarabuying amazon stockmedical devices etfk.t. Precipio Launched its Proprietary HemeScreen AML (Acute Myeloid Leukemia) Molecular Panel. September 22 nd, 2020; Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), launched its ...Proprietary Technologies. Precipio has developed several cutting-edge technologies to provide unparalleled diagnostic accuracy. These technologies help address issues from low cellularity, false negatives in cytogenetics, and slow TAT’s for molecular testing. HemeScreen, and IV-Cell were developed in our lab to solve common industry ... edr nysepsychadelic etf The complaint alleged that Carl Iberger was at the time the CFO of Precipio and learned this confidential information through his position as CFO. According to the complaint, on July 30, 2020, the company announced the agreement and Precipio's stock price rose substantially. Allegedly, the day before the announcement, Timothy Iberger … annheiser bush stock Aug 1, 2023 · Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. Skillsoft’s online learning platform helps organizations to identify and measure skill proficiencies to ensure their workforce stays relevant. The platform makes skilling personalized and accessible, offering a blend of self-paced online courses, hands-on practice, virtual live online classes, and coaching to close skill gaps. FORM 8-K. CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 16, 2022 PRECIPIO, INC.